Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001438533-25-000026
Filing Date
2025-05-01
Accepted
2025-05-01 16:47:20
Documents
97
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tvtx-20250331.htm   iXBRL 10-Q 1413932
2 EX-10.2 ex102-331202510q.htm EX-10.2 15699
3 EX-31.1 tvtx-03312025x10qxex311.htm EX-31.1 12709
4 EX-31.2 tvtx-03312025x10qxex312.htm EX-31.2 12407
5 EX-32.1 tvtx-03312025x10qxex321.htm EX-32.1 8767
6 EX-32.2 tvtx-03312025x10qxex322.htm EX-32.2 8847
12 GRAPHIC image_0a.jpg GRAPHIC 48448
13 GRAPHIC tvtx-20250331_g1.jpg GRAPHIC 60227
  Complete submission text file 0001438533-25-000026.txt   8249747

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tvtx-20250331.xsd EX-101.SCH 54629
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tvtx-20250331_cal.xml EX-101.CAL 93116
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tvtx-20250331_def.xml EX-101.DEF 313171
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tvtx-20250331_lab.xml EX-101.LAB 698100
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tvtx-20250331_pre.xml EX-101.PRE 515245
100 EXTRACTED XBRL INSTANCE DOCUMENT tvtx-20250331_htm.xml XML 985973
Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Filer) CIK: 0001438533 (see all company filings)

EIN.: 262383102 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36257 | Film No.: 25903982
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)